The global electrophysiology market size was valued at USD 14.73 billion in 2025 and is projected to grow from USD 16.88 billion in 2026 to USD 50.26 billion by 2034, registering a CAGR of 14.61% during the forecast period (2026-2034). North America dominated the electrophysiology market with a share of 43.74% in 2025.
The electrophysiology market focuses on technologies and procedures used to study the heart’s electrical signals, identify abnormal electrical pathways, and treat cardiac rhythm disorders. Electrophysiology devices are commonly classified under HSN Code 9018 (instruments and appliances used in medical or surgical procedures) and SIC Code 3841 (Surgical and Medical Instruments and Apparatus).
The electrophysiology market demand is driven by the increasing prevalence of cardiac arrhythmias, growing use of catheter based treatments, and advances in cardiac mapping. Healthcare providers are increasingly using electrophysiology mapping systems and pulsed field ablation systems to identify abnormal electrical pathways and treat rhythm disorders, contributing to electrophysiology market growth.
Download a Free Sample To learn more about this report,
Shift toward Pulsed Field Ablation Technology
The electrophysiology market analysis shows a shift toward pulsed field ablation technology for treating cardiac arrhythmias, particularly atrial fibrillation. This technique uses electrical pulses to target heart tissue while limiting damage to surrounding structures.
Integration of Real-Time Imaging with Electrophysiology Systems
Advances in real time imaging are shaping the electrophysiology market by helping physicians visualize cardiac structures and guide catheter placement during procedures. Integration with mapping systems and imaging technologies improves anatomical assessment and supports more precise navigation during electrophysiology ablation.
Supply chain disruptions are expected to have a high impact on the electrophysiology market share due to dependence on specialized catheters, mapping system components, and semiconductors. The market is expected to follow a stair-step recovery, as shortages of catheter components can affect equipment availability. The market is expected to grow at a CAGR of 14.61%, but supply chain constraints could lower this by 1.5 percentage points, resulting in a growth of around 13.11%. As supply conditions normalize, the electrophysiology market growth is expected to gradually return to 14.61%.
The electrophysiology market forecasts strategic investment activity driven by advancements in cardiac mapping systems, pulsed field ablation technology, and next-generation catheter development.
Key Investment and Funding Activities in Electrophysiology Market, 2026
CoreMap
USD 37 million
In July 2026, CoreMap raised USD 37 million in Series C financing led by Medtronic to advance its high precision electrophysiology mapping platform for atrial fibrillation and accelerate its path toward commercialization.
Catheter Precision, Inc.
Up to USD 36.5 million
In February 2026, the company secured a strategic institutional financing transaction to strengthen its financial position and support business expansion in electrophysiology solutions.
Adoption of Catheter Ablation Procedures and Preference for Minimally Invasive Cardiac Treatments Drives Market
Adoption of catheter ablation procedures is driving the electrophysiology market as healthcare providers increasingly use minimally invasive techniques to treat cardiac arrhythmias, including atrial fibrillation and certain types of supraventricular tachycardia. These procedures rely on electrophysiology catheters, mapping systems, and ablation technologies to identify and treat abnormal electrical pathways in the heart, supporting demand for advanced cardiac rhythm-management equipment.
Healthcare providers increasingly use minimally invasive techniques to treat cardiac arrhythmias, including atrial fibrillation and certain types of supraventricular tachycardia. These procedures rely on electrophysiology catheters, mapping systems, and ablation technologies to identify and treat abnormal electrical pathways in the heart, supporting demand for advanced cardiac rhythm-management equipment.
High Cost of Electrophysiology Procedures and Risk of Complications During Catheter Ablation Restrict Adoption
High cost of electrophysiology procedures can limit patient access to advanced cardiac treatments. Expenses related to catheter ablation, specialized mapping systems, disposable catheters, hospital stays, and post-procedure monitoring can increase the overall treatment cost. Risk of complications during catheter ablation can affect the adoption of electrophysiology procedures. Potential complications include bleeding, blood vessel damage, cardiac perforation, and injury to nearby structures. These risks may require additional monitoring and medical intervention, increasing treatment complexity and costs.
Expansion of Electrophysiology Procedures for Complex Cardiac Arrhythmias and Advanced Cardiac Mapping Offers Growth Opportunities
Medical device manufacturers can target hospitals, cardiac centers, and electrophysiology laboratories treating patients with complex heart rhythm disorders. Advanced mapping systems, ablation catheters, and intracardiac diagnostic devices can support the identification. Revenue can be generated through equipment sales, disposable catheter supplies, system upgrades, and hospital procurement contracts, contributing to electrophysiology market growth.
Electrophysiology equipment providers can serve cardiac centers seeking greater precision in locating the sources of abnormal heart rhythms during diagnostic and ablation procedures. Three-dimensional mapping systems and navigation technologies can help clinicians visualize cardiac electrical activity.
Ablation catheters dominated the product type, with a share of 35.5% in 2025 due to their widespread use in catheter ablation procedures to treat cardiac arrhythmias. These devices help clinicians target and eliminate abnormal electrical signals in the heart.
The mapping and navigation systems segment is projected to grow at a CAGR of 17.5% during the forecast period, driven by its role in identifying the origin and pathways of abnormal electrical activity in the heart.
Request Customizationto receive a tailored report.
Atrial fibrillation led the indication segment, accounting for a share of 54.5% in 2025. This dominance is led by the widespread use of electrophysiology procedures to manage this common cardiac arrhythmia.
Ventricular tachycardia will expand to 15.4% CAGR, driven by the use of electrophysiology procedures to identify and treat abnormal electrical signals originating in the heart's ventricles.
In 2025, hospitals dominated the end user segment with a share of 65.8% in 2025, supported by the availability of specialized electrophysiology laboratories, cardiac specialists, and advanced monitoring equipment.
Ambulatory surgical centers are estimated to achieve a growth rate of 16.8%, fueled by the use of outpatient settings for selected electrophysiology procedures. Their streamlined care models can help eligible patients receive treatment without an overnight hospital stay.
Speak to an Analystto discuss market opportunities.
The North America electrophysiology market accounted for a dominant share of 43.74% in 2025.
U.S. Food and Drug Administration approved Stereotaxis' MAGiC Magnetic Interventional Ablation Catheter for cardiac mapping and ablation in patients with congenital heart disease whose anatomical abnormalities or previous surgeries limit conventional catheter access. This development supports demand for specialized ablation catheters and robotic magnetic navigation systems for complex electrophysiology procedures.
Abbott's Volt Pulsed Field Ablation System was used for the first time in Canada at the McGill University Health Centre in Montreal. The system uses electrical pulses to target cardiac tissue responsible for abnormal rhythms. This is supporting demand for specialized ablation catheters, generators, and electrophysiology laboratory equipment as Canadian centers adopt newer minimally invasive treatment options.
Unlock Regional Insightsto access country-level data, & regional trends.
The Asia Pacific electrophysiology market is expected to grow at a CAGR of 16.39% during the forecast period, making it the fastest-growing region.
Government of India’s Scheme for Strengthening Medical Device Industry, with an outlay of ₹500 crore for FY 2024–25 to FY 2027–28, supports manufacturing capacity, clinical studies, testing infrastructure, and skill development. The Department of Pharmaceuticals reported that 24 projects had been approved under its import-dependence reduction initiative, with grants totalling ₹101.50 crore. These initiatives create opportunities for electrophysiology device manufacturers and suppliers offering cardiac mapping systems.
National Medical Products Administration in China approved a cardiac pulsed field ablation generator and a disposable ablation catheter for treating recurrent, symptomatic atrial fibrillation that does not respond adequately to medication. The approval reflects progress in cardiac ablation equipment development and expands the range of technologies available for electrophysiology procedures.
Japan's National Cerebral and Cardiovascular Center registered the PFA Strain Study in the Japan Registry of Clinical Trials. The multicentre randomized study evaluates pulsed field ablation approaches for persistent atrial fibrillation and examines their effects on left atrial function. The research supports clinical evaluation of cardiac ablation techniques and the use of imaging and electrophysiology technologies.
The Europe electrophysiology market is anticipated to record a growth rate of 14.1% during the forecast period.
Germany's Healthy Heart Act (Gesundes-Herz-Gesetz) aims to strengthen cardiovascular disease prevention, early detection, and structured treatment programs. These measures support improvements across the cardiac care pathway, including the diagnosis and management of heart rhythm disorders. The focus on improving cardiovascular care provides a supportive environment for advanced electrophysiology mapping systems and 3D cardiac mapping technologies.
UK Government's 10 Year Health Plan prioritizes digital transformation, healthcare innovation, and improved access to advanced medical technologies. Its commitment to modernizing clinical services and accelerating the adoption of technology creates opportunities for digital cardiac mapping, three-dimensional visualization systems, and advanced electrophysiology equipment used in arrhythmia diagnosis and treatment.
The Latin America electrophysiology market is estimated to register a growth rate of 13.5% during the forecast period. National Cardiovascular Health Strategy in Brazil provides federal funding to strengthen cardiovascular prevention, diagnosis, and care within primary healthcare services. Mexico's National Strategy for the Prevention and Control of Overweight, Obesity, and Diabetes strengthens the country's broader approach to cardiovascular risk management. This provides a relevant healthcare context for electrocardiographic monitoring systems and electrophysiology equipment.
The Middle East & Africa electrophysiology market is expected to achieve a growth rate of 12.8% during the forecast period. UAE's National Strategy for Wellbeing 2031 emphasizes preventive healthcare. These priorities encourage stronger cardiovascular health management and support the development of specialized diagnostic and treatment services for heart rhythm disorders. South Africa's participation in the Pan-African Society of Cardiology's regional assessment of cardiac arrhythmia treatment services highlights the availability of advanced rhythm management procedures and complex catheter ablation using three-dimensional mapping.
The electrophysiology market competitive landscape is highly fragmented, with established cardiac device manufacturers and specialized cardiac rhythm management companies. Key players such as Abbott, Biosense Webster, Boston Scientific, Medtronic, and BIOTRONIK are estimated to account for 35–40% of the global electrophysiology market share.
Established players compete mainly through cardiac mapping systems, catheter ablation technologie, and cardiac rhythm monitoring. Emerging and regional players in the electrophysiology market ecosystem focus on specialized ablation devices and application-specific solutions for complex cardiac arrhythmias.
September 2026: Medtronic received U.S. FDA clearance and CE Mark for its Affera Prism-2 Mapping Software, alongside CE Mark for the PulseSelect ProxBox Adapter with Proximity Indicator software.
July 2026: Johnson & Johnson received U.S. FDA approval for its Dual Energy THERMOCOOL SMARTTOUCH SF Platform.
Customize This Report to Match Your Strategic Objectives
Author's Details
Research Experts
The Straits Research Team is a group of experienced researchers, analysts, and industry professionals dedicated to delivering reliable, insightful, and well-structured market intelligence. With expertise across multiple sectors and domains, the team combines extensive research, data analysis, and industry knowledge to provide a clear understanding of evolving markets and business environments.
The team focuses on identifying key market trends, emerging opportunities, technological developments, competitive landscapes, and changing industry dynamics. Through a thoughtful and research-driven approach, it aims to provide valuable insights that help businesses, investors, and decision-makers better understand their industries and make informed strategic decisions.
Blood Glucose Monitoring Devices Market Size, Forecast, Demand, Opportunities, 2034
Autoclaves Market Size, Forecast, Demand, Opportunities, 2034
X-Ray Detector Market Size, Share, Growth, Analysis, Report, 2034
Blood Pressure Transducers Market Size, Forecast, Opportunities, 2034
3D Printed Prosthetics Market Size, Forecast, Demand, Opportunities, 2034
We are featured on:
sales@straitsresearch.com